Fujifilm (Thailand) Company Limited participated in the exhibition at APRC 2026 or the 10th meeting of the Asia Pacific International Federation of Anti-TB and Lung Disease Organizations, which this year was held in Bangkok. Between 4 – 7 February 2026, with medical personnel attending the event. policy maker and public health experts from across the Asia-Pacific region It reinforces Fujifilm’s commitment to supporting early screening for lung disease and tuberculosis. Through complete health solutions such as digital X-ray machines with AI, bronchoscopes and the Urine LAM urine test kit with quick results for screening for tuberculosis in the urine. These technologies are designed to increase access to screening to drive timely treatment for underserved and at-risk communities that lack access to health care.
Currently, lung disease and tuberculosis remain public health crises in Thailand and the Asia-Pacific region. Especially among vulnerable populations who lack access to public health services in Thailand, the Ministry of Public Health It revealed that there will be an average of 35 new tuberculosis cases per day by 2024, while lung cancer has become a silent killer. The latest data from 2025 from the National Cancer Institute. Revealed that there are an average of 41 deaths per day. Detecting the disease at an early stage is therefore extremely important. But access to screening is still insufficient in many areas.
Professor Emeritus Dr. Attha Nana, Chairman of the 10th Asia-Pacific International Federation of Anti-TB and Lung Disease Organizations (APRC 2026) and President of the Thai Tuberculosis Suppression Association. under royal patronage Talking about the challenges in eradicating tuberculosis, he said, “Tuberculosis has not yet disappeared from our world and remains a challenging health problem in many countries around the world, including Thailand. Therefore, a knowledge exchange platform like APRC is important. This year’s APRC event hosted by Thailand brought together participants from 36 countries who came together to share experiences and solutions. The main challenge is that only a certain number of people with TB reach treatment. But the other half were sick with tuberculosis but didn’t know they had it. Therefore, screening programs are essential to end tuberculosis.”
Assistant Professor (Special) Dr. Napphalika Kongphonphrom, APRC 2026 Academic Joint Committee Member and Academic Committee Member Urological Association of Thailand under royal patronage Discussing the importance of long-term proactive screening to eliminate tuberculosis, he said, “This APRC academic conference is a good opportunity for Thailand to be the host. The Tuberculosis Suppression Association and the Urological Association of Thailand jointly served as organizers for this event. This gives medical personnel the opportunity to exchange new screening, diagnosis, and treatment methods from public health systems in many countries. What we would like to emphasize is the development of projects that make TB diagnosis and treatment more accessible to patients. The said project must be organized continuously. It is believed that if there is a continuous screening project Thailand will eliminate tuberculosis soon.”
Mr. Takuma Otsuka, Head of Global Marketing and Global Health, Modality Solution Division, Medical Systems Business Division, Fujifilm Corporation, said, “The highlight of Fujifilm’s innovations is that they are designed with patients in mind. To provide safe, convenient use and build confidence for medical personnel. Our innovative low-dose radiograph reduces unnecessary radiation exposure. This is very important for screening and following up on a large scale, such as screening at factories or screening activities in the community. while still maintaining sharp and accurate image quality. as well as efficient workflows For faster diagnosis and improved patient care Especially for deploying mobile medical units in remote areas.”
Fujifilm’s complete medical solution Help medical personnel Technology can be brought to more patients. Reduce health inequality and increase the opportunity to access timely diagnosis and treatment.
- Fujifilm’s digital X-ray machine with AI enables faster and more accurate screening for lung cancer and tuberculosis. Ready to reduce errors in diagnosis and can help detect small lesions that the human eye may not see. Therefore allowing patients to receive treatment more quickly.
- In addition, the rapid-result TB-LAM urine test kit helps detect TB quickly and accurately in HIV patients. Chest X-rays and sputum tests may not provide accurate results. Suitable for use in community health centers and HIV testing clinics. They may not have laboratories and advanced medical equipment for screening.
- As for the Fujifilm bronchoscope, It also helps combine the efficiency of screening with treatment. It helps doctors view the airway to accurately diagnose lung cancer, tuberculosis and complex respiratory diseases. It also helps evaluate early stage lesions by taking tissue samples. In cases where just looking at the images isn’t enough It is a method that is less painful and helps patients receive timely diagnosis and treatment.
Fujifilm aims to support the public health agency’s proactive lung screening project and the “End Tuberculosis” campaign that Thailand has been conducting continuously. Through practical medical solutions in mobile unit deployment This is the potential to provide services to the people outside the hospital. Especially for the proactive inspection project organized by public health departments throughout the country.
Phlin Kamonwat, M.D., qualified medical doctor, Department of Disease Control, Director of the Global Fund Project Management Office Based in Thailand Secretary General of the Tuberculosis Suppression Association of Thailand under royal patronage and the organizing secretary of APRC 2026 emphasized the cooperation of all sectors that “Tuberculosis is a disease of society. It is not just a medical problem that the government can solve alone. Thailand is also a country with a consistently high burden of tuberculosis, with more than 100,000 people suffering from tuberculosis per year. The main challenge is patient access. Especially the group without symptoms Therefore, cooperation from all sectors is required in raising funds, manpower and, indispensable, technology. Currently, we use modern technology to continuously screen the community. Things like mobile X-ray machines and rapid testing will help us reach more patients. If every sector cooperates seriously I believe that we will end the tuberculosis problem in Thailand within the next 5 – 10 years.”
Mr. So Maruo, Managing Director of Fujifilm (Thailand) Co., Ltd. said, “Tuberculosis and lung disease remain important public health challenges. Especially in vulnerable communities, Fujifilm is committed to being a long-term health partner. We believe that detecting disease at an early stage will help reduce losses. Our role is to help health systems reach people faster. Make the diagnosis possible, accurate and timely The heart of the public health system is Speed and equal access, therefore, medical technology must meet the needs of use outside of hospitals and reach communities. Fujifilm aims to develop imaging innovations that are portable and can be used comfortably outside of hospitals. To help raise the level of lung and tuberculosis screening in Thailand.”
Fujifilm moves forward with joining forces with partners Public health agency and medical personnel To expand access to early disease screening and help create a healthy Thai society. In line with the Fujifilm Group’s aim to “Add smiles to our world”
